3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow Bowel Dysfunction: new trials by email Literature Review of Bowel Dysfunction trials Research Report on Bowel Dysfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain Alvimopan, Placebo - Bowel Dysfunction, Constipation | Phase 3 | Completed | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 805 | 2005-08-01 | 2017-08-30 |
| Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain Placebo, Alvimopan, Alviompan - Bowel Dysfunction, Constipation | Phase 3 | Completed | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 485 | 2005-08-01 | 2015-09-02 |
| Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain alvimopan, Placebo - Bowel Dysfunction, Constipation | Phase 3 | Completed | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 518 | 2005-08-01 | 2015-09-02 |
Constipation (3) · Intestinal Diseases (3) · Pain (3)
Digestive System Diseases (3) · Gastrointestinal Diseases (3) · Neurologic Manifestations (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Signs and Symptoms, Digestive (3)
alvimopan (3)
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (3)
Canada (3) · United States (3) · Australia (2) · Austria (2) · Denmark (2) · Finland (2) · Hungary (2) · Ireland (2) · Netherlands (2) · New Zealand (2) · Poland (2) · Spain (2) · Sweden (2) · Switzerland (2) · United Kingdom (2)